Investigating the causal relationship between immune factors and ankylosing spondylitis: insights from a Mendelian Randomization study
- PMID: 39696529
- DOI: 10.1186/s42358-024-00428-1
Investigating the causal relationship between immune factors and ankylosing spondylitis: insights from a Mendelian Randomization study
Abstract
Background: Despite previous studies indicating a close relationship between immune system and ankylosing spondylitis (AS), the causal relationship between them remains unclear.
Methods: Genome-wide association data were utilized to explore the causal link between 731 immune cells and AS using a bidirectional two-sample MR approach. The data included immune cell data from Orrù et al.'s study and AS data from the FinnGen consortium. Cochran's Q test and leave-one-out checked instrument variable (IV) heterogeneity. IVW was the primary method for causal analysis, with MR-Egger and MR-PRESSO addressing horizontal pleiotropy. FDR correction was applied to both analysis directions to rectify multiple testing errors.
Results: In our study, 22 immune phenotypes out of 731 were casually linked to AS. After excluding 5 less robust features, 17 immune factors remained, with 4 being protective and the rest posing risks. Through FDR correction, we found a significant causal relationship between HLA DR on CD14- CD16+ monocyte and AS (OR (95%CI) = 0.70(0.60 ~ 0.83), P = 2.06*10-5). In the reverse analysis with AS as exposure, potential effects on 34 immune features were discovered. After correction, we confirmed significant causal relationships between AS and two immune features, namely CD20- B cell %lymphocyte (OR (95%CI) = 1.16(1.08-1.25), P = 1.91*10-5) and CD20- B cell %B cell (OR (95%CI) = 1.17(1.09-1.26), P = 1.50*10-5).
Conclusions: Our study identified various features associated with AS in different types of immune cells. These findings provide important clues and a theoretical basis for further understanding the pathogenesis of AS, guiding clinical treatment, and drug design.
Keywords: Ankylosing spondylitis; FinnGen; Immune cells; Immunity; Mendelian Randomization.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: We utilized Genome-Wide Association Study (GWAS) information obtained through prior informed consent and ethical approval, permitting its public dissemination. Consent for publication: Not applicable. Competing interests: The authors declare the absence of any competing interests.
Similar articles
-
Causal relationship between the immune cells and ankylosing spondylitis: univariable, bidirectional, and multivariable Mendelian randomization.Front Immunol. 2024 Apr 9;15:1345416. doi: 10.3389/fimmu.2024.1345416. eCollection 2024. Front Immunol. 2024. PMID: 38655262 Free PMC article.
-
Causal relationship between 731 immune cells and the risk of diabetic nephropathy: a two‑sample bidirectional Mendelian randomization study.Ren Fail. 2024 Dec;46(2):2387208. doi: 10.1080/0886022X.2024.2387208. Epub 2024 Aug 1. Ren Fail. 2024. PMID: 39091101 Free PMC article.
-
The mediating role of the genetically predicted N6, N6, N6-trimethyllysine levels in the association between HLA DR on CD14- CD16+ monocytes and ankylosing spondylitis.Medicine (Baltimore). 2024 Dec 13;103(50):e40892. doi: 10.1097/MD.0000000000040892. Medicine (Baltimore). 2024. PMID: 39686417 Free PMC article.
-
Causal role of immune cells in varicose veins: insights from a Mendelian randomization study.Sci Rep. 2025 Jun 4;15(1):19527. doi: 10.1038/s41598-025-03602-7. Sci Rep. 2025. PMID: 40467712 Free PMC article.
-
Causal role of immune cells in prostate cancer: a bidirectional Mendelian-randomization analyses.Aging (Albany NY). 2024 Jun 17;16(12):10477-10488. doi: 10.18632/aging.205942. Epub 2024 Jun 17. Aging (Albany NY). 2024. PMID: 38888513 Free PMC article.
References
-
- Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet (London, England). 2017;390(10089):73–84. https://doi.org/10.1016/s0140-6736(16)31591-4 . - DOI - PubMed
-
- Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol. 2021;17(7):387–404. https://doi.org/10.1038/s41584-021-00625-y . - DOI - PubMed
-
- Costantino F, Talpin A, Said-Nahal R, et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheumatic Dis. 2015;74(4):689–93. https://doi.org/10.1136/annrheumdis-2013-204436 . - DOI
-
- Han Q, Zheng Z, Zhang K, Ding J, Baraliakos X, Zhu P. A comprehensive assessment of hip damage in ankylosing spondylitis, especially early features. Front Immunol. 2021;12:668969. https://doi.org/10.3389/fimmu.2021.668969 . - DOI - PubMed - PMC
-
- Ben-Shabat N, Shabat A, Watad A, et al. Mortality in ankylosing spondylitis according to treatment: a nationwide retrospective cohort study of 5,900 patients from Israel. Arthritis Care Res. 2022;74(10):1614–22. https://doi.org/10.1002/acr.24616 . - DOI
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous